B&D White Capital Company’s Boston Scientific BSX Stock Holding History

B&D White Capital Company’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$418K	Buy	+9,800	New	+$532K	0.04%	78

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Milford Funds Auckland $6.14B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

B&D White Capital Company's BSX Position: Q2 2026 in Review

B&D White Capital Company opened a new position in Boston Scientific (BSX) in Q2 2026: 9,800 shares worth $418K. The stake represents 0.04% of the portfolio and ranks #78 among its holdings.

534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

B&D White Capital Company held 9,800 shares of Boston Scientific worth $418K as of Q2 2026.
Boston Scientific was a new B&D White Capital Company position in Q2 2026.
Boston Scientific made up 0.04% of B&D White Capital Company's portfolio in Q2 2026, its #78 holding.
534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on B&D White Capital Company's 13F filing for Q2 2026, filed 31 Jul 2026.